Thomas, McNerney closes $375m life science fund

The venture capital firm announced the close of its second fund on $375m, which it plans to invest in biotech, pharmaceutical and medical device companies in various stages of development.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this